Black JC

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO, USA.

11 papers · ORCID

ArticlePsychedelics

Risks from self-medicating with psychedelic drugs.

Black JC

Europe PMC2026
ArticlePsilocybin

Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT.

Simonsson O, Bradley M, Black JC +3

Europe PMC2026
ArticlePsychedelics

Improving Psychedelic Harm Reduction and Therapy: Community Perspectives from Individuals Who Use Recreationally and for Mental Health Purposes.

Jewell JS, James C, Black JC

Europe PMC2026
ArticlePsychedelics

Prevalence and predictors of sexual and physical violence during psychedelic use in a US population-based study.

Chwyl C, Ladka MS, Black JC +4

Europe PMC2026
ArticlePsilocybin

Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.

Rockhill KM, Bemis EA, Schow N +5

Europe PMC2026
ArticlePsilocybin

Psilocybin Trends in States That Decriminalized Use.

Black JC, Bau GE, Cook RR +2

Europe PMC2026
ArticlePsilocybin

Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT).

Lyons FE, Rockhill KM, Fox EJ +4

Europe PMC2026
ArticlePsychedelics

Psychedelic Trips: Travel Within the United States to Use Psychedelic Drugs After Legalization.

Black JC, Rockhill KM, Fox EJ +3

Europe PMC2025
ArticleKetamine

Trends in poisonings involving ketamine in the United States, 2019-2023.

Palamar JJ, Jewell JS, El-Shahawy O +1

Europe PMC2025
ArticleKetamine

Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022.

Simon MW, Olsen HA, Hoyte CO +4

Europe PMC2024
ArticlePsilocybin

Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems.

Korthuis PT, Wilson-Poe AR, Black JC +1

Europe PMC2024